How Vaccines Work (They're Drugs Too)
Vaccines are regulated as biologic drugs and work by training the immune system to recognize specific threats. This guide explains the science behind different vaccine types — from traditional killed-virus vaccines to mRNA technology.
Vaccines Are Regulated Biologic Drugs
Vaccines are sometimes discussed separately from "drugs," but from a regulatory standpoint they are biologic drugs — manufactured from or using biological materials, reviewed by the FDA's Center for Biologics Evaluation and Research (CBER), and subject to the same rigorous clinical trial phasesClinical Trial Phases The sequential stages of testing a new drug in humans. Phase I tests safety in 20-100 healthy volunteers. Phase II tests efficacyEfficacy The maximum therapeutic effect a drug can produce, regardless of the dose given. A drug with higher efficacy can achieve a greater maximum response than one with lower efficacy, even if the latter is
Like other drugs, vaccines have approved indications, contraindications, dosing schedules, and known adverse drug reactions. Understanding vaccines pharmacologically helps clarify both how they work and why certain reactions occur.
How the Immune System Learns
The immune system has two arms:
Innate immunity is fast and non-specific — it responds immediately to any foreign invader using general-purpose defenses like fever, inflammation, and natural killer cells.
Adaptive immunity is slower (days to weeks for a first response) but highly specific and, most importantly, it has memory. After encountering a pathogen, specialized B cells produce antibodies that precisely recognize that pathogen. T cells learn to kill infected cells. Both leave behind long-lived memory cells — so the next encounter with the same pathogen triggers a rapid, powerful response before illness can develop.
Vaccines work by triggering this adaptive immune response — creating memory — without causing the actual disease.
Traditional Vaccine Types
Killed (inactivated) vaccines: The pathogen is grown in the lab, then inactivated with chemicals, heat, or radiation so it can no longer replicate. The immune system sees the dead pathogen and builds a response. Examples: inactivated flu vaccine, hepatitis A, polio (IPV), rabies.
Inactivated vaccines cannot cause the disease they protect against because the pathogen is dead. However, they typically require multiple doses and boosters because the immune response is not as robust as with live vaccines.
Live-attenuated vaccines: The pathogen is cultured repeatedly in unfavorable conditions until it loses its ability to cause disease while remaining alive and replicating. The live, weakened pathogen closely mimics a natural infection — triggering a strong, long-lasting immune response, usually with a single dose. Examples: MMR (measles-mumps-rubella), varicella, yellow fever, oral polio (OPV).
Because the pathogen is alive, these vaccines are contraindicated in severely immunocompromised patients — the attenuated virus could, in rare cases, replicate enough to cause disease.
Toxoid vaccines: Some bacteria cause illness through toxins rather than the bacteria themselves (e.g., tetanus, diphtheria). Toxoid vaccines use chemically inactivated toxins to train the immune system to neutralize the toxin. The tetanus booster you receive every 10 years is a toxoid vaccine.
mRNA Vaccines
mRNA (messenger RNA) vaccines represent a newer approach developed with remarkable speed during the COVID-19 pandemic (though the underlying research spans decades).
Instead of delivering any part of the pathogen, mRNA vaccines deliver genetic instructions — a short strand of mRNA — encoding a protein from the pathogen's surface (for COVID-19 vaccines, the spike protein). The mRNA is enclosed in a lipid nanoparticle (a tiny fat bubble) to protect it during delivery and help it enter cells.
Once inside your cells, the mRNA is read by your ribosomes, which build the spike protein. The immune system recognizes the spike protein as foreign and mounts a response — building antibodies and memory cells against it. The mRNA itself degrades within days; it does not enter the cell nucleus and cannot interact with your DNA.
Benefits of mRNA vaccines: - No live pathogen involved — cannot cause infection. - Can be designed and manufactured faster than traditional vaccines. - The platform is adaptable: the mRNA sequence can be updated to match new variants.
Protein Subunit and Viral Vector Vaccines
Protein subunit vaccines: Instead of the whole pathogen or mRNA instructions, these vaccines contain purified pieces of the pathogen — usually surface proteins that the immune system will recognize. The hepatitis B vaccine and most HPV vaccines (Gardasil) use this approach. These vaccines require adjuvants — immune-stimulating additives (like aluminum salts) that boost the immune response to the protein piece.
Viral vector vaccines: A harmless virus (the "vector") is genetically modified to carry instructions for making a pathogen protein. The virus infects cells, which produce the target protein, triggering an immune response. The AstraZeneca and Johnson & Johnson COVID-19 vaccines used this approach, using modified adenoviruses as vectors.
Adverse Drug Reactions from Vaccines
Vaccine adverse drug reactions (ADRs) fall into predictable categories:
Local reactions (very common): Redness, swelling, and pain at the injection site — caused by the initial innate immune response. These indicate the vaccine is working.
Systemic reactions (common): Fever, fatigue, muscle aches, and headache in the 1–2 days following vaccination — again caused by the immune system being activated. These are particularly common after the second dose of mRNA vaccines, which occurs when memory cells already primed from the first dose encounter the antigen again and mount a rapid, robust response.
Allergic reactions (rare): True anaphylaxis occurs in approximately 1–2 per million doses for most vaccines. This is why vaccination clinics observe recipients for 15–30 minutes after injection. The polyethylene glycol (PEG) component of mRNA vaccine lipid nanoparticles has been identified as a potential allergen in those with prior PEG sensitization.
Rare serious events: Myocarditis (heart inflammation) has been observed at a low rate following mRNA COVID-19 vaccination — primarily in young males after the second dose. The absolute risk is very low, and the myocarditis is typically mild and resolves. Thrombosis with thrombocytopenia syndrome (TTS) was observed with some adenoviral vector vaccines at rates of approximately 1–4 per million doses.
Understanding these ADR profiles — similar to any drug — allows healthcare providers to counsel patients and identify who may need alternative vaccine options.
Key Takeaways
- Vaccines are biologic drugs regulated through the same FDA clinical trial framework as other medicines.
- They work by triggering adaptive immune memory — creating antibodies and memory cells that protect against future infection without causing the disease.
- Inactivated vaccines use dead pathogens; live-attenuated vaccines use weakened live pathogens; toxoid vaccines target bacterial toxins; mRNA vaccines deliver instructions for making a single pathogen protein.
- mRNA vaccines do not alter DNA; the mRNA degrades within days after the immune response is initiated.
- Common adverse drug reactions (injection site pain, fever, fatigue) reflect the immune system activating — the intended effect. Rare serious reactions (anaphylaxis, myocarditis) are monitored through post-marketing surveillance.